Company / Financials
NP Life Sciences Health Industry Group Inc. Financials
FY2019-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableRevenue
$164.6K
FY2023 · +61.4% YoY
Net Income
-$2.9K
FY2023 · +84.4% YoY
Profit Margin
-1.8%
FY2023 · net income / revenue
ROE
-17.9%
FY2023 · return on equity
Total Assets
$76.9K
FY2023
Total Debt
-
FY2023
Equity
$16.4K
FY2023
ROA
-3.8%
FY2023 · return on assets
Statement paths
Financial highlights
Key Data Points
- Altman Z-Score -1.61 (distress zone, below 1.23 threshold)
- Accrual-heavy earnings: Net income significantly exceeds operating cash flow
Data sourced from SEC EDGAR filings. Not investment advice.
Metric history
Revenue HistoryTotal revenue from operations$164.6K+61.4% YoYNet Income HistoryProfit after all expenses and taxes-$2.9K+84.4% YoYOperating Income HistoryProfit from core business operations before interest and taxes-$690+96.3% YoYSG&A Expense HistorySelling, general, and administrative expenses$165.3K+36.8% YoYInterest Expense HistoryCost of borrowing and debt obligations$645+64400.0% YoYIncome Tax HistoryTotal income tax expense$1.6KEPS (Basic) HistoryBasic earnings per share$0.00EPS (Diluted) HistoryDiluted earnings per share including stock options and convertibles$0.00Shares Outstanding HistoryWeighted average diluted shares outstanding43.0M0.0% YoYTotal Assets HistoryTotal value of all assets owned$76.9K-39.8% YoY